Stay updated on Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.

Latest updates to the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now shows a Locations section with Ohio as the study site, clarifying where the trial is conducted. The HHS Vulnerability Disclosure link and Ohio Locations label have been removed as minor footer/navigation updates.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved the government funding status notice from the page, a minor change that does not affect trial details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedNo meaningful updates detected to the Study Details page; the content and layout appear unchanged between screenshots.SummaryDifference0.5%

- Check89 days agoChange DetectedMajor change: updated operating status notice and version to v3.2.0; removed reference to v3.1.0.SummaryDifference3%

- Check96 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.